BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 40808)

  • 1. Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study.
    Schwarcz R; Hökfelt T; Fuxe K; Jonsson G; Goldstein M; Terenius L
    Exp Brain Res; 1979 Oct; 37(2):199-216. PubMed ID: 40808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kainic acid neurotoxicity; effect of systemic injection on neurotransmitter markers in different brain regions.
    Heggli DE; Aamodt A; Malthe-Sørenssen D
    Brain Res; 1981 Dec; 230(1-2):253-62. PubMed ID: 6119136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal lesions with kainic acid: neurochemical characteristics.
    Schwarcz R; Coyle JT
    Brain Res; 1977 May; 127(2):235-49. PubMed ID: 16686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An animal model for Huntington's disease.
    Coyle JT
    Biol Psychiatry; 1979 Apr; 14(2):251-76. PubMed ID: 38864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibotenate-induced neuronal degeneration in immature rat brain.
    Steiner HX; McBean GJ; Köhler C; Roberts PJ; Schwarcz R
    Brain Res; 1984 Jul; 307(1-2):117-24. PubMed ID: 6466990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and distant neuronal degeneration following intrastriatal injection of kainic acid.
    Zaczek R; Simonton S; Coyle JT
    J Neuropathol Exp Neurol; 1980 May; 39(3):245-64. PubMed ID: 6154134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite turning effects of dainic and ibotenic acid injected in the rat substantia nigra.
    Porceddu ML; Piacente B; Morelli M; Di Chiara G
    Neurosci Lett; 1979 Dec; 15(2-3):271-6. PubMed ID: 231244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra cell death from kainic acid or folic acid injections into the pontine tegmentum.
    McGeer EG; McGeer PL
    Brain Res; 1984 Apr; 298(2):339-42. PubMed ID: 6144364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
    Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
    Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that [3H]forskolin binding in the substantia nigra is intrinsic to a striatal-nigral projection: an autoradiographic study of rat brain.
    Gehlert DR; Dawson TM; Filloux FM; Sanna E; Hanbauer I; Wamsley JK
    Neurosci Lett; 1987 Jan; 73(2):114-8. PubMed ID: 3822243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term sequelae of striatal kainate lesion.
    Zaczek R; Schwarcz R; Coyle JT
    Brain Res; 1978 Sep; 152(3):626-32. PubMed ID: 28812
    [No Abstract]   [Full Text] [Related]  

  • 12. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat.
    Sperk G; Berger M; Hörtnagl H; Hornykiewicz O
    Eur J Pharmacol; 1981 Sep; 74(4):279-86. PubMed ID: 6170518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intracranial infusions of colchicine and ibotenic acid as models of neurodegeneration in the basal forebrain.
    Shaughnessy LW; Barone S; Mundy WR; Herr DW; Tilson HA
    Brain Res; 1994 Feb; 637(1-2):15-26. PubMed ID: 8180792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat brain.
    Castel MN; Morino P; Frey P; Terenius L; Hökfelt T
    Neuroscience; 1993 Aug; 55(3):833-47. PubMed ID: 8105419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting.
    Isacson O; Brundin P; Gage FH; Björklund A
    Neuroscience; 1985 Dec; 16(4):799-817. PubMed ID: 2936982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic relationships between cortical and dopaminergic inputs and intrinsic GABAergic systems within intrastriatal striatal grafts.
    Clarke DJ; Dunnett SB
    J Chem Neuroanat; 1993; 6(3):147-58. PubMed ID: 8102060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral asymmetries and neurochemical changes after unilateral lesions of tuberomammillary nucleus or substantia nigra.
    Maisonnette S; Huston JP; Brandao M; Schwarting RK
    Exp Brain Res; 1998 Jun; 120(3):273-82. PubMed ID: 9628414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a GABAergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat.
    Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
    Brain Res; 1979 Nov; 176(2):273-84. PubMed ID: 40667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distant blood-brain barrier opening in subfields of the rat hippocampus after intrastriatal injections of kainic acid but not ibotenic acid.
    Nitsch C; Hubauer H
    Neurosci Lett; 1986 Feb; 64(1):53-8. PubMed ID: 3960388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
    Javoy F; Sotelo C; Herbet A; Agid Y
    Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.